These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19442656

  • 1. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells.
    Matsunaga T, Arakaki M, Kamiya T, Endo S, El-Kabbani O, Hara A.
    Chem Biol Interact; 2009 Sep 14; 181(1):52-60. PubMed ID: 19442656
    [Abstract] [Full Text] [Related]

  • 2. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.
    Matsunaga T, Kamiya T, Sumi D, Kumagai Y, Kalyanaraman B, Hara A.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1191-202. PubMed ID: 18206670
    [Abstract] [Full Text] [Related]

  • 3. 9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3.
    Matsunaga T, Hosogai M, Arakaki M, Endo S, El-Kabbani O, Hara A.
    Biol Pharm Bull; 2012 Mar 15; 35(9):1598-602. PubMed ID: 22975515
    [Abstract] [Full Text] [Related]

  • 4. 9,10-Phenanthrenequinone promotes secretion of pulmonary aldo-keto reductases with surfactant.
    Matsunaga T, Haga M, Watanabe G, Shinoda Y, Endo S, Kajiwara Y, Tanaka H, Inagaki N, El-Kabbani O, Hara A.
    Cell Tissue Res; 2012 Feb 15; 347(2):407-17. PubMed ID: 22281686
    [Abstract] [Full Text] [Related]

  • 5. Aldo-keto reductase 1C15 as a quinone reductase in rat endothelial cell: its involvement in redox cycling of 9,10-phenanthrenequinone.
    Matsunaga T, Shinoda Y, Inoue Y, Shimizu Y, Haga M, Endo S, El-Kabbani O, Hara A.
    Free Radic Res; 2011 Jul 15; 45(7):848-57. PubMed ID: 21623689
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide mitigates apoptosis in human endothelial cells induced by 9,10-phenanthrenequinone: role of proteasomal function.
    Matsunaga T, Arakaki M, Kamiya T, Haga M, Endo S, El-Kabbani O, Hara A.
    Toxicology; 2010 Feb 09; 268(3):191-7. PubMed ID: 20026164
    [Abstract] [Full Text] [Related]

  • 7. The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3.
    Guise CP, Abbattista MR, Singleton RS, Holford SD, Connolly J, Dachs GU, Fox SB, Pollock R, Harvey J, Guilford P, Doñate F, Wilson WR, Patterson AV.
    Cancer Res; 2010 Feb 15; 70(4):1573-84. PubMed ID: 20145130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies.
    Byrns MC, Steckelbroeck S, Penning TM.
    Biochem Pharmacol; 2008 Jan 15; 75(2):484-93. PubMed ID: 17950253
    [Abstract] [Full Text] [Related]

  • 10. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
    Matsunaga T, Morikawa Y, Haga M, Endo S, Soda M, Yamamura K, El-Kabbani O, Tajima K, Ikari A, Hara A.
    Toxicol Appl Pharmacol; 2014 Jul 15; 278(2):180-9. PubMed ID: 24813866
    [Abstract] [Full Text] [Related]

  • 11. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
    Marín YE, Seiberg M, Lin CB.
    Exp Dermatol; 2009 Jul 15; 18(7):611-8. PubMed ID: 19320734
    [Abstract] [Full Text] [Related]

  • 12. Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1.
    Matsunaga T, Kamase K, Takasawa H, Yamaji Y, Endo S, El-Kabbani O, Ikari A.
    Chem Biol Interact; 2018 Jan 05; 279():10-20. PubMed ID: 29108775
    [Abstract] [Full Text] [Related]

  • 13. The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.
    Birtwistle J, Hayden RE, Khanim FL, Green RM, Pearce C, Davies NJ, Wake N, Schrewe H, Ride JP, Chipman JK, Bunce CM.
    Mutat Res; 2009 Mar 09; 662(1-2):67-74. PubMed ID: 19162045
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM, Samara EN, Wong C, Metwalli A, Krlin R, Bane B, Liu CZ, Yang JT, Pitha JV, Culkin DJ, Kropp BP, Penning TM, Lin HK.
    Endocr Relat Cancer; 2006 Mar 09; 13(1):169-80. PubMed ID: 16601286
    [Abstract] [Full Text] [Related]

  • 15. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors.
    Penning TM, Steckelbroeck S, Bauman DR, Miller MW, Jin Y, Peehl DM, Fung KM, Lin HK.
    Mol Cell Endocrinol; 2006 Mar 27; 248(1-2):182-91. PubMed ID: 16417966
    [Abstract] [Full Text] [Related]

  • 16. 9,10-phenanthrenequinone, a component of diesel exhaust particles, inhibits the reduction of 4-benzoylpyridine and all-trans-retinal and mediates superoxide formation through its redox cycling in pig heart.
    Shimada H, Oginuma M, Hara A, Imamura Y.
    Chem Res Toxicol; 2004 Aug 27; 17(8):1145-50. PubMed ID: 15310246
    [Abstract] [Full Text] [Related]

  • 17. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J, Malcekova B, Skarka A, Novotna E, Wsol V.
    Toxicol Appl Pharmacol; 2014 Aug 01; 278(3):238-48. PubMed ID: 24832494
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
    Lin HK, Steckelbroeck S, Fung KM, Jones AN, Penning TM.
    Steroids; 2004 Dec 01; 69(13-14):795-801. PubMed ID: 15582534
    [Abstract] [Full Text] [Related]

  • 19. AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
    Skarydová L, Zivná L, Xiong G, Maser E, Wsól V.
    Chem Biol Interact; 2009 Mar 16; 178(1-3):138-44. PubMed ID: 19007764
    [Abstract] [Full Text] [Related]

  • 20. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T, Xu F, Xu J, Liu L, Chen Y.
    Biomed Pharmacother; 2015 Feb 16; 69():317-25. PubMed ID: 25661377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.